MBRA 3.0: integrating the mucus environment for advanced high-throughput in vitro intestinal microbiome modeling.

Gut Microbes · 2026 · PMC12795259 · PMID 41520283

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In contrast, isovalerate and isobutyrate showed a decreasing trend over time under both conditions, without significant condition-dependent differences ( Figure 6C,E,G ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;b&gt;MBRA 3.0: integrating the mucus environment for advanced high-throughput&lt;/b&gt; &lt;i&gt;&lt;b&gt;in vitro&lt;/b&gt;&lt;/i&gt; &lt;b&gt;intestinal microbiome modeling&lt;/b&gt;.

The sentences

<b>MBRA 3.0: integrating the mucus environment for advanced high-throughput</b> <i><b>in vitro</b></i> <b>intestinal microbiome modeling</b>.